Stock Market Today: Higher Close for Stocks, Palantir Soars on AI Optimism
While the main indexes made modest moves Tuesday, Palantir Technologies soared 30% after earnings.
Stocks opened higher Tuesday as investors attempted to look past Federal Reserve Chair Jerome Powell's hawkish appearance on "60 Minutes." However, the main indexes ran out of steam as the session wore on as more central bankers took the wait-and-see route toward rate cuts.
The major benchmarks all closed lower Monday after Powell's Sunday night appearance on CBS' "60 Minutes" reiterated what he said following last week's Fed meeting. Specifically, Powell insisted that the Fed will not cut interest rates until it is confident inflation is sustainably moving toward the 2% central bank's target.
The S&P 500 (+0.2% at 4,954) and the Nasdaq Composite (+0.07% at 15,609) traded in negative territory for most of the afternoon after Cleveland Fed President Loretta Mester said "it would be a mistake" to cut rates too soon. "Doing so would undermine all the good work that has gone into getting inflation to this point," she said at a bankers meeting in Columbus, Ohio. Still, the two managed to eke out modest gains by the close.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The Dow Jones Industrial Average outperformed, adding 0.4% to 38,521 thanks to strength in blue chip stocks Walgreens Boots Alliance (WBA, +4.3%) and Nike (NKE, +2.9%).
Palantir stock pops as artificial intelligence platform demand soars
Looking beyond Dow Jones stocks, Palantir Technologies (PLTR) soared 30.8% after the data analytics platform reported higher-than-expected fourth-quarter earnings of 8 cents per share. Revenue of $608 million also beat estimates. And while the company guided for lower-than-anticipated first-quarter revenue, its full-year forecast is higher than Wall Street is expecting.
Additionally, in Palantir's subsequent earnings call, Chief Revenue Officer and Chief Legal Officer Ryan Turner noted that demand for Palantir's Artificial Intelligence Platform (AIP) is "off the charts." This is evidenced by the 103 deals closed in the fourth-quarter that are worth at least $1 million each.
"We are impressed with AI Platform ramping faster than our initial expectations and believe it's appropriate to upgrade shares to reflect the momentum," said Jefferies analyst Brent Thill, who lifted his rating on PLTR stock to Hold from Underperform (Sell). Thill also said he's encouraged by Palantir's full-year free cash flow guidance – a first for the company – of $800 million to $1 billion.
Weight-loss drugs give Eli Lilly's Q4 results a boost
Eli Lilly (LLY, -0.2%) was another notable name in the earnings spotlight. The drugmaker's foray into the weight-loss drug market helped it deliver impressive fourth-quarter results, with earnings per share soaring 19% year-over-year to $2.49. Revenue surged 28% to $9.4 billion. Both figures beat analysts' estimates.
The company's financial results were boosted in part by sales for its type 2 diabetes drug Mounjaro, which rose to $2.2 billion from $279 million in the year-ago period. Revenue from its weight-loss drug Zepbound, which launched in early December, was $175.8 million.
These drugs have also helped boost LLY's share price, with the healthcare stock more than doubling over the past 12 months. And with a $668.7 billion market cap, Eli Lilly is now one of the world's most valuable companies.
Related content
- Amazon To Raise MGM+ Streaming Service Prices
- How to Earn a Decent Yield From Your Sweep Account
- Kiplinger's Earnings Calendar for This Week (Feb. 5-9)
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Setting Objective Criteria for Employee Bonuses Aligned With Company Goals
When employees win, the company wins.
By Stephen Nalley Published
-
A Modern Guide to Money Etiquette: Gifts, Tips, Splitting Bills and More
What is modern money etiquette? The customs for splitting a restaurant check, purchasing a wedding gift, tipping and more have evolved. These guidelines can help.
By Emma Patch Published
-
Potential Ripple Effects of Taxing Unrealized Capital Gains
The proposed tax on unrealized gains would be limited to those with a net worth above $100 million, but some see a broad impact on markets and businesses.
By Brian Skrobonja, Chartered Financial Consultant (ChFC®) Published
-
Succession Musts: Thoughtful Planning and Frank Discussions
When it comes to passing on the family business, you don't want anyone to be surprised about who will control or inherit the business after the owner's death.
By David Handler, J.D. Published
-
How to Navigate Finances as a Blended Family
If you’re planning to become part of a blended family, consider these financial issues as you and your spouse start a new life.
By Ella Vincent Published
-
Here's How to Find Your Way Out of the Inherited IRA Maze
To navigate complex rules on inherited IRAs and RMDs, start by breaking down key terms and common scenarios. A clearer picture of your next steps will emerge.
By Evan T. Beach, CFP®, AWMA® Published
-
Stock Market Today: Stocks Rally on Strong Netflix Earnings
Mega-cap tech leads the charge as markets rise for a sixth straight week.
By Dan Burrows Published
-
Why American Express Earnings Have the Dow Stock Lower
American Express is the worst Dow Jones stock Friday after the payments giant reported a top-line miss in its third quarter. Here's what you need to know.
By Joey Solitro Published
-
CVS Stock Falls After Karen Lynch Ouster: What to Know
CVS stock is lower Friday after the embattled healthcare company said Karen Lynch is out as CEO, effective immediately
By Joey Solitro Published
-
Netflix Stock Jumps to the Top of the S&P 500 After Earnings. Here's Why
Netflix stock is spiking Friday after the streaming giant beat third-quarter expectations and gave an upbeat fourth-quarter outlook.
By Joey Solitro Published